But the report, on the experiences of 13 patients, found that the drug had no benefit for some people and that some who benefited said the improvement didn’t last.
The increases are to list prices, which do not include rebates to pharmacy benefit managers and other discounts.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback